What is a stock summary page? Click here for an overview.
Business Description
TELA Bio Inc
NAICS : 334510
SIC : 3845
ISIN : US8723811084
Share Class Description:
TELA: Ordinary SharesDescription
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.28 | |||||
| Equity-to-Asset | 0.33 | |||||
| Debt-to-Equity | 1.45 | |||||
| Debt-to-EBITDA | -1.26 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -9.01 | |||||
| Beneish M-Score | -1.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22 | |||||
| 3-Year EBITDA Growth Rate | 2.4 | |||||
| 3-Year EPS without NRI Growth Rate | 2.9 | |||||
| 3-Year FCF Growth Rate | 1.6 | |||||
| 3-Year Book Growth Rate | -39 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 24.91 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.31 | |||||
| 9-Day RSI | 12.62 | |||||
| 14-Day RSI | 17.34 | |||||
| 3-1 Month Momentum % | -7.34 | |||||
| 6-1 Month Momentum % | 14.22 | |||||
| 12-1 Month Momentum % | -53.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.01 | |||||
| Quick Ratio | 4.19 | |||||
| Cash Ratio | 3.38 | |||||
| Days Inventory | 212.86 | |||||
| Days Sales Outstanding | 52.78 | |||||
| Days Payable | 38.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.3 | |||||
| Shareholder Yield % | -1.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.08 | |||||
| Operating Margin % | -60.17 | |||||
| Net Margin % | -54.61 | |||||
| FCF Margin % | -61.45 | |||||
| ROE % | -324.42 | |||||
| ROA % | -54.11 | |||||
| ROIC % | -208.67 | |||||
| 3-Year ROIIC % | -125.27 | |||||
| ROC (Joel Greenblatt) % | -231.37 | |||||
| ROCE % | -60.53 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.5 | |||||
| PB Ratio | 1.85 | |||||
| Price-to-Tangible-Book | 1.96 | |||||
| EV-to-EBIT | -1.35 | |||||
| EV-to-EBITDA | -1.39 | |||||
| EV-to-Forward-EBITDA | -5.85 | |||||
| EV-to-Revenue | 0.64 | |||||
| EV-to-Forward-Revenue | 0.51 | |||||
| EV-to-FCF | -2.53 | |||||
| Price-to-GF-Value | 0.17 | |||||
| Price-to-Net-Current-Asset-Value | 2.61 | |||||
| Earnings Yield (Greenblatt) % | -74.07 | |||||
| FCF Yield % | -81.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TELA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TELA Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 69.3 | ||
| EPS (TTM) ($) | -1.39 | ||
| Beta | 0.42 | ||
| 3-Year Sharpe Ratio | -0.85 | ||
| 3-Year Sortino Ratio | -1.06 | ||
| Volatility % | 54.73 | ||
| 14-Day RSI | 17.34 | ||
| 14-Day ATR ($) | 0.221857 | ||
| 20-Day SMA ($) | 2.2995 | ||
| 12-1 Month Momentum % | -53.75 | ||
| 52-Week Range ($) | 1.2805 - 6.5 | ||
| Shares Outstanding (Mil) | 39.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TELA Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TELA Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
TELA Bio Inc Frequently Asked Questions
What is TELA Bio Inc(TELA)'s stock price today?
The current price of TELA is $1.33. The 52 week high of TELA is $6.50 and 52 week low is $1.28.
When is next earnings date of TELA Bio Inc(TELA)?
The next earnings date of TELA Bio Inc(TELA) is 2025-05-09 Est..
Does TELA Bio Inc(TELA) pay dividends? If so, how much?
TELA Bio Inc(TELA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers